About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (39)
View allTotal Trials
39
As Lead Sponsor
34
As Collaborator
5
Total Enrollment
14,418
By Phase
PHASE2/PHASE3: 1PHASE3: 12PHASE4: 1PHASE2: 12PHASE1: 13
By Status
COMPLETED: 32WITHDRAWN: 3RECRUITING: 2NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline39 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07086755Collaborator
Vadadustat for the Treatment of Nonintubated Acute Respiratory Distress Syndrome Due to Pathogen-Associated Lung Injury
PHASE2/PHASE3Not yet recruiting
1,100 participants
Started: Aug 1, 2025 · Completed: Jul 1, 2026
NCT06901505Lead Sponsor
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
PHASE3Recruiting
350 participants
Started: Jul 24, 2025 · Completed: Jun 30, 2026
NCT05082571Lead Sponsor
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease
PHASE3Withdrawn
Started: Jan 31, 2025 · Completed: Oct 31, 2026
NCT05082584Lead Sponsor
Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease Naive to Erythropoiesis-Stimulating Agents
PHASE3Withdrawn
Started: Jan 31, 2025 · Completed: Oct 31, 2026
NCT06520826Collaborator
Vafseo Outcomes In-Center Experience
PHASE3Recruiting
2,200 participants
Started: Nov 20, 2024 · Completed: Jun 30, 2026
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...